|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ACIN1-RIN3 (FusionGDB2 ID:HG22985TG79890) |
Fusion Gene Summary for ACIN1-RIN3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ACIN1-RIN3 | Fusion gene ID: hg22985tg79890 | Hgene | Tgene | Gene symbol | ACIN1 | RIN3 | Gene ID | 22985 | 79890 |
| Gene name | apoptotic chromatin condensation inducer 1 | Ras and Rab interactor 3 | |
| Synonyms | ACINUS|ACN|fSAP152 | - | |
| Cytomap | ('ACIN1')('RIN3') 14q11.2 | 14q32.12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | apoptotic chromatin condensation inducer in the nucleusfunctional spliceosome-associated protein 152 | ras and Rab interactor 3RAB5 interacting protein 3ras interaction/interference protein 3 | |
| Modification date | 20200313 | 20200320 | |
| UniProtAcc | Q9UKV3 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000262710, ENST00000555053, ENST00000605057, ENST00000338631, ENST00000357481, ENST00000397341, ENST00000457657, ENST00000555352, ENST00000557515, | ||
| Fusion gene scores | * DoF score | 12 X 11 X 4=528 | 15 X 16 X 7=1680 |
| # samples | 13 | 18 | |
| ** MAII score | log2(13/528*10)=-2.02202630633 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/1680*10)=-3.22239242133645 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ACIN1 [Title/Abstract] AND RIN3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ACIN1(23559191)-RIN3(93081747), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | ACIN1-RIN3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACIN1-RIN3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ACIN1-RIN3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ACIN1-RIN3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ACIN1 | GO:0030263 | apoptotic chromosome condensation | 10490026 |
| Fusion gene breakpoints across ACIN1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across RIN3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for ACIN1-RIN3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000605057 | ENST00000216487 | ACIN1 | chr14 | 23559191 | - | RIN3 | chr14 | 93081747 | + | 0.006736086 | 0.99326384 |
| ENST00000262710 | ENST00000216487 | ACIN1 | chr14 | 23559191 | - | RIN3 | chr14 | 93081747 | + | 0.006347295 | 0.9936527 |
| ENST00000555053 | ENST00000216487 | ACIN1 | chr14 | 23559191 | - | RIN3 | chr14 | 93081747 | + | 0.00624713 | 0.9937529 |
Top |
Fusion Genomic Features for ACIN1-RIN3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| ACIN1 | chr14 | 23559190 | - | RIN3 | chr14 | 93081751 | + | 0.002616324 | 0.99738365 |
| ACIN1 | chr14 | 23559190 | - | RIN3 | chr14 | 93081751 | + | 0.002616324 | 0.99738365 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for ACIN1-RIN3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr14:23559191/chr14:93081747) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ACIN1 | . |
| FUNCTION: Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets; ACIN1 confers RNA-binding to the complex. The ASAP complex can inhibit RNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. Induces apoptotic chromatin condensation after activation by CASP3. Regulates cyclin A1, but not cyclin A2, expression in leukemia cells. {ECO:0000269|PubMed:10490026, ECO:0000269|PubMed:12665594, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:22203037, ECO:0000269|PubMed:22388736}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000262710 | - | 4 | 19 | 72_106 | 203 | 1342.0 | Domain | SAP |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000555053 | - | 4 | 19 | 72_106 | 203 | 1329.0 | Domain | SAP |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 248_514 | 122 | 986.0 | Compositional bias | Note=Pro-rich | |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 722_725 | 122 | 986.0 | Compositional bias | Note=Poly-Thr | |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 965_972 | 122 | 986.0 | Compositional bias | Note=Poly-Gly | |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 703_846 | 122 | 986.0 | Domain | VPS9 | |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 877_963 | 122 | 986.0 | Domain | Ras-associating |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000262710 | - | 4 | 19 | 1114_1131 | 203 | 1342.0 | Compositional bias | Note=Pro-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000262710 | - | 4 | 19 | 1132_1341 | 203 | 1342.0 | Compositional bias | Note=Arg/Asp/Glu/Lys-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000262710 | - | 4 | 19 | 142_442 | 203 | 1342.0 | Compositional bias | Note=Glu-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000262710 | - | 4 | 19 | 573_676 | 203 | 1342.0 | Compositional bias | Note=Ser-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000338631 | - | 1 | 12 | 1114_1131 | 0 | 615.0 | Compositional bias | Note=Pro-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000338631 | - | 1 | 12 | 1132_1341 | 0 | 615.0 | Compositional bias | Note=Arg/Asp/Glu/Lys-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000338631 | - | 1 | 12 | 142_442 | 0 | 615.0 | Compositional bias | Note=Glu-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000338631 | - | 1 | 12 | 573_676 | 0 | 615.0 | Compositional bias | Note=Ser-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000357481 | - | 1 | 13 | 1114_1131 | 0 | 584.0 | Compositional bias | Note=Pro-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000357481 | - | 1 | 13 | 1132_1341 | 0 | 584.0 | Compositional bias | Note=Arg/Asp/Glu/Lys-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000357481 | - | 1 | 13 | 142_442 | 0 | 584.0 | Compositional bias | Note=Glu-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000357481 | - | 1 | 13 | 573_676 | 0 | 584.0 | Compositional bias | Note=Ser-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000397341 | - | 1 | 12 | 1114_1131 | 0 | 584.0 | Compositional bias | Note=Pro-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000397341 | - | 1 | 12 | 1132_1341 | 0 | 584.0 | Compositional bias | Note=Arg/Asp/Glu/Lys-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000397341 | - | 1 | 12 | 142_442 | 0 | 584.0 | Compositional bias | Note=Glu-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000397341 | - | 1 | 12 | 573_676 | 0 | 584.0 | Compositional bias | Note=Ser-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000555053 | - | 4 | 19 | 1114_1131 | 203 | 1329.0 | Compositional bias | Note=Pro-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000555053 | - | 4 | 19 | 1132_1341 | 203 | 1329.0 | Compositional bias | Note=Arg/Asp/Glu/Lys-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000555053 | - | 4 | 19 | 142_442 | 203 | 1329.0 | Compositional bias | Note=Glu-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000555053 | - | 4 | 19 | 573_676 | 203 | 1329.0 | Compositional bias | Note=Ser-rich |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000338631 | - | 1 | 12 | 72_106 | 0 | 615.0 | Domain | SAP |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000357481 | - | 1 | 13 | 72_106 | 0 | 584.0 | Domain | SAP |
| Hgene | ACIN1 | chr14:23559191 | chr14:93081747 | ENST00000397341 | - | 1 | 12 | 72_106 | 0 | 584.0 | Domain | SAP |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 24_29 | 122 | 986.0 | Compositional bias | Note=Poly-Glu | |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 63_158 | 122 | 986.0 | Domain | SH2 |
Top |
Fusion Gene Sequence for ACIN1-RIN3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >1313_1313_1_ACIN1-RIN3_ACIN1_chr14_23559191_ENST00000262710_RIN3_chr14_93081747_ENST00000216487_length(transcript)=4271nt_BP=938nt CTTTTCTCTCGAAGGGCACCCGAAGATTGTCACGAGTCCTTAGACTCCAACTACTGCGGCAGCTTCCAAATTTCCTGAAAACCCTAAGCT GGGCCAGCCCGGCAGCCCACGCACTTCCGGCCTCGGACCCGCCCCAAACACCCAAGCGCCCCAGCGCCTCATCTCTAGGTCCGGAAATAA ACGAACATCTCCGATTATGGTTATACCAGGGTCGAGGGTTTCCGAATATATTCGATTCAAAGCTTCGGCAAGACGAAGAAAACCGAGCCT GAAAGCAGGGCGAGAAAAGGGGCGCTGCAGGGCGGATGGAAAGAATTGATTGGTAACGATGTGGAGACGGAAACATCCGAGGACATCCGG AGGAACCCGGGGAGTTCTGAGTGGTAATCGAGGGGTAGAGTATGGCAGTGGGCGGGGTCATCTCGGTACGTTCGAAGGGCGTTGGCGGAA ATTACCGAAGATGCCCGAAGCCGTCGGGACGGACCCGAGTACCTCACGCAAGATGGCGGAGCTGGAGGAGGTGACTCTGGACGGGAAGCC TCTTCAGGCGCTGCGGGTGACCGACCTGAAGGCCGCACTGGAGCAGCGAGGCCTAGCCAAGAGCGGGCAGAAGAGTGCCCTGGTCAAGCG GCTCAAAGGGGCTCTAATGCTAGAAAATTTACAGAAACACTCAACACCCCATGCTGCATTCCAGCCAAATTCCCAGATTGGTGAGGAAAT GAGCCAGAACAGTTTCATAAAACAGTATCTGGAAAAGCAGCAGGAGCTACTTAGGCAGCGTCTGGAACGTGAAGCTCGAGAAGCTGCAGA ACTTGAAGAAGCTTCAGCTGAGTCGGAGGACGAGATGATCCATCCTGAGGGAGTGGCTTCCCTGCTGCCTCCTGACTTTCAGAGCAGCCT GGAGAGACCAGAGCTGGAGCTCAGCAGACATTCGCCCATATTGTACCTGGAAGGCTCGGCTCTTGTGTTTGAGGACATCTTCAGATTGAT TGCGTTCTACTGTGTCAGTAGAGACTTACTGCCCTTCACACTGCGGCTACCCCAGGCCATCCTTGAGGCCAGCAGCTTCACGGACCTTGA GACCATCGCCAACCTGGGTCTGGGTTTCTGGGACTCCTCGCTGAATCCTCCACAAGAAAGAGGGAAGCCAGCAGAGCCCCCAAGAGACCG GGCCCCCGGATTCCCCCTAGTCTCCAGCCTCAGGCCCACAGCCCATGACGCAAACTGTGCCTGTGAAATCGAGCTGTCGGTAGGAAATGA CCGCCTGTGGTTTGTGAATCCTATTTTCATCGAGGACTGCAGCAGCGCCCTGCCCACCGACCAGCCACCTCTTGGAAATTGCCCTGCACG CCCTTTGCCGCCCACCTCTGATGCCACCTCACCCACCTCCAGGTGGGCCCCACGCCGCCCACCACCCCCTCCCCCAGTGCTGCCCCTGCA GCCCTGCAGCCCAGCCCAGCCCCCTGTGCTCCCTGCTCTTGCCCCCGCCCCTGCCTGTCCTTTGCCCACCTCTCCCCCAGTGCCTGCCCC CCACGTCACACCCCATGCCCCAGGTCCCCCAGACCATCCGAACCAGCCGCCCATGATGACCTGCGAGAGACTCCCATGCCCCACTGCAGG CCTGGGCCCCCTCAGGGAGGAAGCGATGAAGCCAGGGGCAGCCTCCAGTCCCTTGCAGCAGGTCCCCGCCCCGCCACTGCCTGCGAAGAA GAACCTTCCCACTGCCCCTCCCAGACGCCGCGTTTCCGAGAGGGTGTCCTTAGAAGACCAAAGTCCGGGGATGGCGGCAGAGGGGGACCA GCTCAGCCTGCCTCCCCAAGGGACCTCAGACGGCCCTGAGGACACGCCCCGGGAGAGCACGGAGCAAGGCCAGGACACAGAGGTGAAAGC CAGCGATCCTCACAGCATGCCAGAGCTGCCCAGGACAGCCAAACAACCCCCAGTCCCGCCCCCCAGGAAAAAACGGATCTCTCGACAACT GGCCTCGACCCTCCCAGCTCCCTTAGAGAACGCTGAGCTCTGCACACAGGCGATGGCCTTGGAGACACCCACGCCGGGTCCACCCAGAGA GGGCCAAAGCCCTGCTTCTCAGGCTGGGACTCAGCACCCTCCTGCCCAGGCCACTGCCCATTCCCAGAGCTCTCCAGAGTTCAAGGGCTC CCTGGCCTCCCTCTCAGACAGCTTGGGGGTGTCTGTCATGGCCACCGACCAGGACTCCTACTCCACCAGCAGCACGGAGGAGGAGCTGGA GCAGTTCAGCAGCCCCAGCGTGAAGAAGAAGCCCTCCATGATCCTGGGCAAGGCTCGGCACCGGCTGAGCTTTGCCAGTTTCAGCAGCAT GTTCCACGCTTTCCTCTCCAACAACCGCAAGCTGTACAAGAAGGTGGTGGAGCTGGCGCAGGACAAGGGCTCGTACTTTGGCAGCCTGGT GCAGGACTACAAGGTGTACAGCCTGGAGATGATGGCGCGCCAGACCTCCAGCACGGAGATGCTGCAGGAGATTCGCACCATGATGACCCA GCTCAAGAGCTACCTGCTGCAGAGCACCGAGCTCAAGGCCCTGGTGGACCCCGCCCTGCACTCCGAGGAGGAGCTCGAAGCAATTGTAGA GTCTGCCTTGTACAAATGTGTCCTGAAGCCCCTGAAGGAAGCCATCAACTCATGCCTGCATCAGATCCACAGCAAGGATGGTTCGCTGCA GCAGCTCAAGGAGAACCAGTTAGTGATCCTGGCCACCACCACCACTGACCTAGGTGTGACCACCAGCGTGCCGGAGGTGCCCATGATGGA GAAGATCCTGCAGAAGTTCACCAGCATGCACAAGGCCTACTCACCTGAGAAGAAGATCTCCATCCTGCTCAAGACCTGCAAACTCATCTA CGACTCCATGGCCCTCGGCAACCCAGGGAAGCCCTATGGGGCGGATGACTTCCTGCCTGTGCTCATGTATGTGCTGGCCCGCAGCAACCT CACGGAGATGCTTCTCAATGTGGAGTACATGATGGAGCTCATGGACCCCGCCCTGCAGCTGGGGGAGGGTTCCTACTATCTGACCACCAC CTACGGGGCCCTGGAGCACATCAAGAGCTACGACAAGATCACGGTGACCCGGCAGCTGAGTGTGGAGGTGCAGGACTCCATCCACCGCTG GGAGCGCCGGCGTACTCTCAACAAGGCCCGGGCCTCCCGCTCCTCCGTACAGGACTTCATCTGCGTGTCGTACCTGGAGCCCGAGCAGCA GGCGCGGACGCTGGCGTCGCGGGCGGACACCCAGGCCCAGGCGCTGTGCGCGCAGTGCGCGGAGAAGTTCGCGGTGGAGCGGCCGCAGGC GCACCGGCTGTTCGTGCTGGTGGACGGGCGCTGCTTCCAGCTGGCGGACGACGCGCTGCCGCACTGCATCAAGGGCTACCTGCTGCGCAG CGAGCCCAAGCGCGACTTCCACTTTGTCTACCGGCCCCTGGACGGTGGTGGCGGCGGCGGCGGCGGGAGCCCGCCCTGCCTGGTGGTGCG GGAGCCCAACTTCCTGTGAGGCCCTCCCGGGGCGCCTCCCCTCACCCCCAGGCGCACGTCTGGCCCCGCCTCTGGCTGCGCACTCCCGAC CGCGACGTCCACGCAGCAGAGGGACATGGGCCATTCCATGACGTGCCCAGGCCAACGTCGCAGGACAGTTGTGAAAATAACATGACGCTC GTCCAAGGCCACTTCCTGAGGGCAAGTCCTAATAGCCCTGAGACACCGAGACGGCATGTTCTTCATTAGACGGAAAGGGAAACTGAGGCT CAGGAGAGAGGCGCTCCAGGCCGCTGCAGCCAACAAACCGGCGCCCTCTTCACACGTAGCTCCTCAGGCCATTCCCCATGAGTCCCCCAC ACCCACCCCATCCTCGGTCTTTGCAAAGAAGGGCCCGAGCTTAGTTTCCCCAGGACTGGCCTAGGAAGGAGCACCGGCCACAGCTGCTCC CCGTGCCACTCAGGGTGGACCCAGCATCTCAGGAGCACCTCAGGGTGTCGGTTAAGAGACAGGCCTCCACCCCTGCACCAGAGCCTGCTC TTAGCTCCCGGTGCCCCCAGACCCCGCAGCTCTGTGCCCGGCAAGAAGCAGCTAGACACACGCCAGGGCGCCAAGCACGGCCAGCTCCGC GGACCCATGGACAAGCCCAGCCCCGCCTCAGGGAAAACAGGGCCTTTCCCTACAGGACACGCCCCAGAGCTGTGGCAGATTGCAGGAGCC >1313_1313_1_ACIN1-RIN3_ACIN1_chr14_23559191_ENST00000262710_RIN3_chr14_93081747_ENST00000216487_length(amino acids)=1069AA_BP=118 MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPILYLEGSALVFEDIFRLIAFYCVSRDLLPFTLRLPQAILEASSFTDLETIANLGLGFWDSSLNP PQERGKPAEPPRDRAPGFPLVSSLRPTAHDANCACEIELSVGNDRLWFVNPIFIEDCSSALPTDQPPLGNCPARPLPPTSDATSPTSRWA PRRPPPPPPVLPLQPCSPAQPPVLPALAPAPACPLPTSPPVPAPHVTPHAPGPPDHPNQPPMMTCERLPCPTAGLGPLREEAMKPGAASS PLQQVPAPPLPAKKNLPTAPPRRRVSERVSLEDQSPGMAAEGDQLSLPPQGTSDGPEDTPRESTEQGQDTEVKASDPHSMPELPRTAKQP PVPPPRKKRISRQLASTLPAPLENAELCTQAMALETPTPGPPREGQSPASQAGTQHPPAQATAHSQSSPEFKGSLASLSDSLGVSVMATD QDSYSTSSTEEELEQFSSPSVKKKPSMILGKARHRLSFASFSSMFHAFLSNNRKLYKKVVELAQDKGSYFGSLVQDYKVYSLEMMARQTS STEMLQEIRTMMTQLKSYLLQSTELKALVDPALHSEEELEAIVESALYKCVLKPLKEAINSCLHQIHSKDGSLQQLKENQLVILATTTTD LGVTTSVPEVPMMEKILQKFTSMHKAYSPEKKISILLKTCKLIYDSMALGNPGKPYGADDFLPVLMYVLARSNLTEMLLNVEYMMELMDP ALQLGEGSYYLTTTYGALEHIKSYDKITVTRQLSVEVQDSIHRWERRRTLNKARASRSSVQDFICVSYLEPEQQARTLASRADTQAQALC -------------------------------------------------------------- >1313_1313_2_ACIN1-RIN3_ACIN1_chr14_23559191_ENST00000555053_RIN3_chr14_93081747_ENST00000216487_length(transcript)=4040nt_BP=707nt TCGATTCAAAGCTTCGGCAAGACGAAGAAAACCGAGCCTGAAAGCAGGGCGAGAAAAGGGGCGCTGCAGGGCGGATGGAAAGAATTGATT GGTAACGATGTGGAGACGGAAACATCCGAGGACATCCGGAGGAACCCGGGGAGTTCTGAGTGGTAATCGAGGGGTAGAGTATGGCAGTGG GCGGGGTCATCTCGGTACGTTCGAAGGGCGTTGGCGGAAATTACCGAAGATGCCCGAAGCCGTCGGGACGGACCCGAGTACCTCACGCAA GATGGCGGAGCTGGAGGAGGTGACTCTGGACGGGAAGCCTCTTCAGGCGCTGCGGGTGACCGACCTGAAGGCCGCACTGGAGCAGCGAGG CCTAGCCAAGAGCGGGCAGAAGAGTGCCCTGGTCAAGCGGCTCAAAGGGGCTCTAATGCTAGAAAATTTACAGAAACACTCAACACCCCA TGCTGCATTCCAGCCAAATTCCCAGATTGGTGAGGAAATGAGCCAGAACAGTTTCATAAAACAGTATCTGGAAAAGCAGCAGGAGCTACT TAGGCAGCGTCTGGAACGTGAAGCTCGAGAAGCTGCAGAACTTGAAGAAGCTTCAGCTGAGTCGGAGGACGAGATGATCCATCCTGAGGG AGTGGCTTCCCTGCTGCCTCCTGACTTTCAGAGCAGCCTGGAGAGACCAGAGCTGGAGCTCAGCAGACATTCGCCCATATTGTACCTGGA AGGCTCGGCTCTTGTGTTTGAGGACATCTTCAGATTGATTGCGTTCTACTGTGTCAGTAGAGACTTACTGCCCTTCACACTGCGGCTACC CCAGGCCATCCTTGAGGCCAGCAGCTTCACGGACCTTGAGACCATCGCCAACCTGGGTCTGGGTTTCTGGGACTCCTCGCTGAATCCTCC ACAAGAAAGAGGGAAGCCAGCAGAGCCCCCAAGAGACCGGGCCCCCGGATTCCCCCTAGTCTCCAGCCTCAGGCCCACAGCCCATGACGC AAACTGTGCCTGTGAAATCGAGCTGTCGGTAGGAAATGACCGCCTGTGGTTTGTGAATCCTATTTTCATCGAGGACTGCAGCAGCGCCCT GCCCACCGACCAGCCACCTCTTGGAAATTGCCCTGCACGCCCTTTGCCGCCCACCTCTGATGCCACCTCACCCACCTCCAGGTGGGCCCC ACGCCGCCCACCACCCCCTCCCCCAGTGCTGCCCCTGCAGCCCTGCAGCCCAGCCCAGCCCCCTGTGCTCCCTGCTCTTGCCCCCGCCCC TGCCTGTCCTTTGCCCACCTCTCCCCCAGTGCCTGCCCCCCACGTCACACCCCATGCCCCAGGTCCCCCAGACCATCCGAACCAGCCGCC CATGATGACCTGCGAGAGACTCCCATGCCCCACTGCAGGCCTGGGCCCCCTCAGGGAGGAAGCGATGAAGCCAGGGGCAGCCTCCAGTCC CTTGCAGCAGGTCCCCGCCCCGCCACTGCCTGCGAAGAAGAACCTTCCCACTGCCCCTCCCAGACGCCGCGTTTCCGAGAGGGTGTCCTT AGAAGACCAAAGTCCGGGGATGGCGGCAGAGGGGGACCAGCTCAGCCTGCCTCCCCAAGGGACCTCAGACGGCCCTGAGGACACGCCCCG GGAGAGCACGGAGCAAGGCCAGGACACAGAGGTGAAAGCCAGCGATCCTCACAGCATGCCAGAGCTGCCCAGGACAGCCAAACAACCCCC AGTCCCGCCCCCCAGGAAAAAACGGATCTCTCGACAACTGGCCTCGACCCTCCCAGCTCCCTTAGAGAACGCTGAGCTCTGCACACAGGC GATGGCCTTGGAGACACCCACGCCGGGTCCACCCAGAGAGGGCCAAAGCCCTGCTTCTCAGGCTGGGACTCAGCACCCTCCTGCCCAGGC CACTGCCCATTCCCAGAGCTCTCCAGAGTTCAAGGGCTCCCTGGCCTCCCTCTCAGACAGCTTGGGGGTGTCTGTCATGGCCACCGACCA GGACTCCTACTCCACCAGCAGCACGGAGGAGGAGCTGGAGCAGTTCAGCAGCCCCAGCGTGAAGAAGAAGCCCTCCATGATCCTGGGCAA GGCTCGGCACCGGCTGAGCTTTGCCAGTTTCAGCAGCATGTTCCACGCTTTCCTCTCCAACAACCGCAAGCTGTACAAGAAGGTGGTGGA GCTGGCGCAGGACAAGGGCTCGTACTTTGGCAGCCTGGTGCAGGACTACAAGGTGTACAGCCTGGAGATGATGGCGCGCCAGACCTCCAG CACGGAGATGCTGCAGGAGATTCGCACCATGATGACCCAGCTCAAGAGCTACCTGCTGCAGAGCACCGAGCTCAAGGCCCTGGTGGACCC CGCCCTGCACTCCGAGGAGGAGCTCGAAGCAATTGTAGAGTCTGCCTTGTACAAATGTGTCCTGAAGCCCCTGAAGGAAGCCATCAACTC ATGCCTGCATCAGATCCACAGCAAGGATGGTTCGCTGCAGCAGCTCAAGGAGAACCAGTTAGTGATCCTGGCCACCACCACCACTGACCT AGGTGTGACCACCAGCGTGCCGGAGGTGCCCATGATGGAGAAGATCCTGCAGAAGTTCACCAGCATGCACAAGGCCTACTCACCTGAGAA GAAGATCTCCATCCTGCTCAAGACCTGCAAACTCATCTACGACTCCATGGCCCTCGGCAACCCAGGGAAGCCCTATGGGGCGGATGACTT CCTGCCTGTGCTCATGTATGTGCTGGCCCGCAGCAACCTCACGGAGATGCTTCTCAATGTGGAGTACATGATGGAGCTCATGGACCCCGC CCTGCAGCTGGGGGAGGGTTCCTACTATCTGACCACCACCTACGGGGCCCTGGAGCACATCAAGAGCTACGACAAGATCACGGTGACCCG GCAGCTGAGTGTGGAGGTGCAGGACTCCATCCACCGCTGGGAGCGCCGGCGTACTCTCAACAAGGCCCGGGCCTCCCGCTCCTCCGTACA GGACTTCATCTGCGTGTCGTACCTGGAGCCCGAGCAGCAGGCGCGGACGCTGGCGTCGCGGGCGGACACCCAGGCCCAGGCGCTGTGCGC GCAGTGCGCGGAGAAGTTCGCGGTGGAGCGGCCGCAGGCGCACCGGCTGTTCGTGCTGGTGGACGGGCGCTGCTTCCAGCTGGCGGACGA CGCGCTGCCGCACTGCATCAAGGGCTACCTGCTGCGCAGCGAGCCCAAGCGCGACTTCCACTTTGTCTACCGGCCCCTGGACGGTGGTGG CGGCGGCGGCGGCGGGAGCCCGCCCTGCCTGGTGGTGCGGGAGCCCAACTTCCTGTGAGGCCCTCCCGGGGCGCCTCCCCTCACCCCCAG GCGCACGTCTGGCCCCGCCTCTGGCTGCGCACTCCCGACCGCGACGTCCACGCAGCAGAGGGACATGGGCCATTCCATGACGTGCCCAGG CCAACGTCGCAGGACAGTTGTGAAAATAACATGACGCTCGTCCAAGGCCACTTCCTGAGGGCAAGTCCTAATAGCCCTGAGACACCGAGA CGGCATGTTCTTCATTAGACGGAAAGGGAAACTGAGGCTCAGGAGAGAGGCGCTCCAGGCCGCTGCAGCCAACAAACCGGCGCCCTCTTC ACACGTAGCTCCTCAGGCCATTCCCCATGAGTCCCCCACACCCACCCCATCCTCGGTCTTTGCAAAGAAGGGCCCGAGCTTAGTTTCCCC AGGACTGGCCTAGGAAGGAGCACCGGCCACAGCTGCTCCCCGTGCCACTCAGGGTGGACCCAGCATCTCAGGAGCACCTCAGGGTGTCGG TTAAGAGACAGGCCTCCACCCCTGCACCAGAGCCTGCTCTTAGCTCCCGGTGCCCCCAGACCCCGCAGCTCTGTGCCCGGCAAGAAGCAG CTAGACACACGCCAGGGCGCCAAGCACGGCCAGCTCCGCGGACCCATGGACAAGCCCAGCCCCGCCTCAGGGAAAACAGGGCCTTTCCCT >1313_1313_2_ACIN1-RIN3_ACIN1_chr14_23559191_ENST00000555053_RIN3_chr14_93081747_ENST00000216487_length(amino acids)=1069AA_BP=118 MVTMWRRKHPRTSGGTRGVLSGNRGVEYGSGRGHLGTFEGRWRKLPKMPEAVGTDPSTSRKMAELEEVTLDGKPLQALRVTDLKAALEQR GLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELLRQRLEREAREAAELEEASAESEDEMIHPE GVASLLPPDFQSSLERPELELSRHSPILYLEGSALVFEDIFRLIAFYCVSRDLLPFTLRLPQAILEASSFTDLETIANLGLGFWDSSLNP PQERGKPAEPPRDRAPGFPLVSSLRPTAHDANCACEIELSVGNDRLWFVNPIFIEDCSSALPTDQPPLGNCPARPLPPTSDATSPTSRWA PRRPPPPPPVLPLQPCSPAQPPVLPALAPAPACPLPTSPPVPAPHVTPHAPGPPDHPNQPPMMTCERLPCPTAGLGPLREEAMKPGAASS PLQQVPAPPLPAKKNLPTAPPRRRVSERVSLEDQSPGMAAEGDQLSLPPQGTSDGPEDTPRESTEQGQDTEVKASDPHSMPELPRTAKQP PVPPPRKKRISRQLASTLPAPLENAELCTQAMALETPTPGPPREGQSPASQAGTQHPPAQATAHSQSSPEFKGSLASLSDSLGVSVMATD QDSYSTSSTEEELEQFSSPSVKKKPSMILGKARHRLSFASFSSMFHAFLSNNRKLYKKVVELAQDKGSYFGSLVQDYKVYSLEMMARQTS STEMLQEIRTMMTQLKSYLLQSTELKALVDPALHSEEELEAIVESALYKCVLKPLKEAINSCLHQIHSKDGSLQQLKENQLVILATTTTD LGVTTSVPEVPMMEKILQKFTSMHKAYSPEKKISILLKTCKLIYDSMALGNPGKPYGADDFLPVLMYVLARSNLTEMLLNVEYMMELMDP ALQLGEGSYYLTTTYGALEHIKSYDKITVTRQLSVEVQDSIHRWERRRTLNKARASRSSVQDFICVSYLEPEQQARTLASRADTQAQALC -------------------------------------------------------------- >1313_1313_3_ACIN1-RIN3_ACIN1_chr14_23559191_ENST00000605057_RIN3_chr14_93081747_ENST00000216487_length(transcript)=3810nt_BP=477nt TGCCCGAAGCCGTCGGGACGGACCCGAGTACCTCACGCAAGATGGCGGAGCTGGAGGAGGTGACTCTGGACGGGAAGCCTCTTCAGGCGC TGCGGGTGACCGACCTGAAGGCCGCACTGGAGCAGCGAGGCCTAGCCAAGAGCGGGCAGAAGAGTGCCCTGGTCAAGCGGCTCAAAGGGG CTCTAATGCTAGAAAATTTACAGAAACACTCAACACCCCATGCTGCATTCCAGCCAAATTCCCAGATTGGTGAGGAAATGAGCCAGAACA GTTTCATAAAACAGTATCTGGAAAAGCAGCAGGAGCTACTTAGGCAGCGTCTGGAACGTGAAGCTCGAGAAGCTGCAGAACTTGAAGAAG CTTCAGCTGAGTCGGAGGACGAGATGATCCATCCTGAGGGAGTGGCTTCCCTGCTGCCTCCTGACTTTCAGAGCAGCCTGGAGAGACCAG AGCTGGAGCTCAGCAGACATTCGCCCATATTGTACCTGGAAGGCTCGGCTCTTGTGTTTGAGGACATCTTCAGATTGATTGCGTTCTACT GTGTCAGTAGAGACTTACTGCCCTTCACACTGCGGCTACCCCAGGCCATCCTTGAGGCCAGCAGCTTCACGGACCTTGAGACCATCGCCA ACCTGGGTCTGGGTTTCTGGGACTCCTCGCTGAATCCTCCACAAGAAAGAGGGAAGCCAGCAGAGCCCCCAAGAGACCGGGCCCCCGGAT TCCCCCTAGTCTCCAGCCTCAGGCCCACAGCCCATGACGCAAACTGTGCCTGTGAAATCGAGCTGTCGGTAGGAAATGACCGCCTGTGGT TTGTGAATCCTATTTTCATCGAGGACTGCAGCAGCGCCCTGCCCACCGACCAGCCACCTCTTGGAAATTGCCCTGCACGCCCTTTGCCGC CCACCTCTGATGCCACCTCACCCACCTCCAGGTGGGCCCCACGCCGCCCACCACCCCCTCCCCCAGTGCTGCCCCTGCAGCCCTGCAGCC CAGCCCAGCCCCCTGTGCTCCCTGCTCTTGCCCCCGCCCCTGCCTGTCCTTTGCCCACCTCTCCCCCAGTGCCTGCCCCCCACGTCACAC CCCATGCCCCAGGTCCCCCAGACCATCCGAACCAGCCGCCCATGATGACCTGCGAGAGACTCCCATGCCCCACTGCAGGCCTGGGCCCCC TCAGGGAGGAAGCGATGAAGCCAGGGGCAGCCTCCAGTCCCTTGCAGCAGGTCCCCGCCCCGCCACTGCCTGCGAAGAAGAACCTTCCCA CTGCCCCTCCCAGACGCCGCGTTTCCGAGAGGGTGTCCTTAGAAGACCAAAGTCCGGGGATGGCGGCAGAGGGGGACCAGCTCAGCCTGC CTCCCCAAGGGACCTCAGACGGCCCTGAGGACACGCCCCGGGAGAGCACGGAGCAAGGCCAGGACACAGAGGTGAAAGCCAGCGATCCTC ACAGCATGCCAGAGCTGCCCAGGACAGCCAAACAACCCCCAGTCCCGCCCCCCAGGAAAAAACGGATCTCTCGACAACTGGCCTCGACCC TCCCAGCTCCCTTAGAGAACGCTGAGCTCTGCACACAGGCGATGGCCTTGGAGACACCCACGCCGGGTCCACCCAGAGAGGGCCAAAGCC CTGCTTCTCAGGCTGGGACTCAGCACCCTCCTGCCCAGGCCACTGCCCATTCCCAGAGCTCTCCAGAGTTCAAGGGCTCCCTGGCCTCCC TCTCAGACAGCTTGGGGGTGTCTGTCATGGCCACCGACCAGGACTCCTACTCCACCAGCAGCACGGAGGAGGAGCTGGAGCAGTTCAGCA GCCCCAGCGTGAAGAAGAAGCCCTCCATGATCCTGGGCAAGGCTCGGCACCGGCTGAGCTTTGCCAGTTTCAGCAGCATGTTCCACGCTT TCCTCTCCAACAACCGCAAGCTGTACAAGAAGGTGGTGGAGCTGGCGCAGGACAAGGGCTCGTACTTTGGCAGCCTGGTGCAGGACTACA AGGTGTACAGCCTGGAGATGATGGCGCGCCAGACCTCCAGCACGGAGATGCTGCAGGAGATTCGCACCATGATGACCCAGCTCAAGAGCT ACCTGCTGCAGAGCACCGAGCTCAAGGCCCTGGTGGACCCCGCCCTGCACTCCGAGGAGGAGCTCGAAGCAATTGTAGAGTCTGCCTTGT ACAAATGTGTCCTGAAGCCCCTGAAGGAAGCCATCAACTCATGCCTGCATCAGATCCACAGCAAGGATGGTTCGCTGCAGCAGCTCAAGG AGAACCAGTTAGTGATCCTGGCCACCACCACCACTGACCTAGGTGTGACCACCAGCGTGCCGGAGGTGCCCATGATGGAGAAGATCCTGC AGAAGTTCACCAGCATGCACAAGGCCTACTCACCTGAGAAGAAGATCTCCATCCTGCTCAAGACCTGCAAACTCATCTACGACTCCATGG CCCTCGGCAACCCAGGGAAGCCCTATGGGGCGGATGACTTCCTGCCTGTGCTCATGTATGTGCTGGCCCGCAGCAACCTCACGGAGATGC TTCTCAATGTGGAGTACATGATGGAGCTCATGGACCCCGCCCTGCAGCTGGGGGAGGGTTCCTACTATCTGACCACCACCTACGGGGCCC TGGAGCACATCAAGAGCTACGACAAGATCACGGTGACCCGGCAGCTGAGTGTGGAGGTGCAGGACTCCATCCACCGCTGGGAGCGCCGGC GTACTCTCAACAAGGCCCGGGCCTCCCGCTCCTCCGTACAGGACTTCATCTGCGTGTCGTACCTGGAGCCCGAGCAGCAGGCGCGGACGC TGGCGTCGCGGGCGGACACCCAGGCCCAGGCGCTGTGCGCGCAGTGCGCGGAGAAGTTCGCGGTGGAGCGGCCGCAGGCGCACCGGCTGT TCGTGCTGGTGGACGGGCGCTGCTTCCAGCTGGCGGACGACGCGCTGCCGCACTGCATCAAGGGCTACCTGCTGCGCAGCGAGCCCAAGC GCGACTTCCACTTTGTCTACCGGCCCCTGGACGGTGGTGGCGGCGGCGGCGGCGGGAGCCCGCCCTGCCTGGTGGTGCGGGAGCCCAACT TCCTGTGAGGCCCTCCCGGGGCGCCTCCCCTCACCCCCAGGCGCACGTCTGGCCCCGCCTCTGGCTGCGCACTCCCGACCGCGACGTCCA CGCAGCAGAGGGACATGGGCCATTCCATGACGTGCCCAGGCCAACGTCGCAGGACAGTTGTGAAAATAACATGACGCTCGTCCAAGGCCA CTTCCTGAGGGCAAGTCCTAATAGCCCTGAGACACCGAGACGGCATGTTCTTCATTAGACGGAAAGGGAAACTGAGGCTCAGGAGAGAGG CGCTCCAGGCCGCTGCAGCCAACAAACCGGCGCCCTCTTCACACGTAGCTCCTCAGGCCATTCCCCATGAGTCCCCCACACCCACCCCAT CCTCGGTCTTTGCAAAGAAGGGCCCGAGCTTAGTTTCCCCAGGACTGGCCTAGGAAGGAGCACCGGCCACAGCTGCTCCCCGTGCCACTC AGGGTGGACCCAGCATCTCAGGAGCACCTCAGGGTGTCGGTTAAGAGACAGGCCTCCACCCCTGCACCAGAGCCTGCTCTTAGCTCCCGG TGCCCCCAGACCCCGCAGCTCTGTGCCCGGCAAGAAGCAGCTAGACACACGCCAGGGCGCCAAGCACGGCCAGCTCCGCGGACCCATGGA CAAGCCCAGCCCCGCCTCAGGGAAAACAGGGCCTTTCCCTACAGGACACGCCCCAGAGCTGTGGCAGATTGCAGGAGCCATCGTGTGGGG >1313_1313_3_ACIN1-RIN3_ACIN1_chr14_23559191_ENST00000605057_RIN3_chr14_93081747_ENST00000216487_length(amino acids)=1008AA_BP=57 MAELEEVTLDGKPLQALRVTDLKAALEQRGLAKSGQKSALVKRLKGALMLENLQKHSTPHAAFQPNSQIGEEMSQNSFIKQYLEKQQELL RQRLEREAREAAELEEASAESEDEMIHPEGVASLLPPDFQSSLERPELELSRHSPILYLEGSALVFEDIFRLIAFYCVSRDLLPFTLRLP QAILEASSFTDLETIANLGLGFWDSSLNPPQERGKPAEPPRDRAPGFPLVSSLRPTAHDANCACEIELSVGNDRLWFVNPIFIEDCSSAL PTDQPPLGNCPARPLPPTSDATSPTSRWAPRRPPPPPPVLPLQPCSPAQPPVLPALAPAPACPLPTSPPVPAPHVTPHAPGPPDHPNQPP MMTCERLPCPTAGLGPLREEAMKPGAASSPLQQVPAPPLPAKKNLPTAPPRRRVSERVSLEDQSPGMAAEGDQLSLPPQGTSDGPEDTPR ESTEQGQDTEVKASDPHSMPELPRTAKQPPVPPPRKKRISRQLASTLPAPLENAELCTQAMALETPTPGPPREGQSPASQAGTQHPPAQA TAHSQSSPEFKGSLASLSDSLGVSVMATDQDSYSTSSTEEELEQFSSPSVKKKPSMILGKARHRLSFASFSSMFHAFLSNNRKLYKKVVE LAQDKGSYFGSLVQDYKVYSLEMMARQTSSTEMLQEIRTMMTQLKSYLLQSTELKALVDPALHSEEELEAIVESALYKCVLKPLKEAINS CLHQIHSKDGSLQQLKENQLVILATTTTDLGVTTSVPEVPMMEKILQKFTSMHKAYSPEKKISILLKTCKLIYDSMALGNPGKPYGADDF LPVLMYVLARSNLTEMLLNVEYMMELMDPALQLGEGSYYLTTTYGALEHIKSYDKITVTRQLSVEVQDSIHRWERRRTLNKARASRSSVQ DFICVSYLEPEQQARTLASRADTQAQALCAQCAEKFAVERPQAHRLFVLVDGRCFQLADDALPHCIKGYLLRSEPKRDFHFVYRPLDGGG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ACIN1-RIN3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| Tgene | RIN3 | chr14:23559191 | chr14:93081747 | ENST00000216487 | 2 | 10 | 587_732 | 122.33333333333333 | 986.0 | RAB5B |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ACIN1-RIN3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ACIN1-RIN3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ACIN1 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
| Tgene | C0029401 | Osteitis Deformans | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies